# SOME DESCRIPTIVE TITLE.
# Copyright (C) YEAR THE PACKAGE'S COPYRIGHT HOLDER
# This file is distributed under the same license as the PACKAGE package.
# FIRST AUTHOR <EMAIL@ADDRESS>, YEAR.
#
#, fuzzy
msgid ""
msgstr ""
"Project-Id-Version: PACKAGE VERSION\n"
"Report-Msgid-Bugs-To: \n"
"POT-Creation-Date: 2020-05-16 18:02+0200\n"
"PO-Revision-Date: YEAR-MO-DA HO:MI+ZONE\n"
"Last-Translator: FULL NAME <EMAIL@ADDRESS>\n"
"Language-Team: LANGUAGE <LL@li.org>\n"
"Language: \n"
"MIME-Version: 1.0\n"
"Content-Type: text/plain; charset=UTF-8\n"
"Content-Transfer-Encoding: 8bit\n"
"Plural-Forms: nplurals=2; plural=(n > 1);\n"

#: BSPQ20E3/panel/templates/base.html:13
msgid "Title"
msgstr "Titre"

#: BSPQ20E3/panel/templates/base.html:59
#: BSPQ20E3/panel/templates/basewithbar.html:79
msgid "My account"
msgstr "Mon compte"

#: BSPQ20E3/panel/templates/base.html:60
msgid "Log out"
msgstr "Fermer la session"

#: BSPQ20E3/panel/templates/base.html:65
#: BSPQ20E3/panel/templates/basewithbar.html:85
msgid "Sign in"
msgstr "Commencer la session"

#: BSPQ20E3/panel/templates/basewithbar.html:11
msgid "Social login"
msgstr "Informations"

#: BSPQ20E3/panel/templates/basewithbar.html:17
msgid "We only allow social login due to security and simplicity reasons"
msgstr ""
"Nous autorisons uniquement la connexion sociale pour des raisons de sécurité "
"et de simplicité"

#: BSPQ20E3/panel/templates/basewithbar.html:26
msgid "Close"
msgstr "Fermer"

#: BSPQ20E3/panel/templates/basewithbar.html:38
#, fuzzy
#| msgid "My account"
msgid "Your account"
msgstr "Mon compte"

#: BSPQ20E3/panel/templates/basewithbar.html:47
#, fuzzy
#| msgid "My account"
msgid "Delete account"
msgstr "Mon compte"

#: BSPQ20E3/panel/templates/basewithbar.html:48
msgid "Save changes"
msgstr "Enregistrer les modifications"

#: BSPQ20E3/panel/templates/basewithbar.html:49
msgid "Close without saving"
msgstr "Fermer sans enregistrer"

#: BSPQ20E3/panel/templates/basewithbar.html:63
msgid "Main"
msgstr "Général"

#: BSPQ20E3/panel/templates/basewithbar.html:67
msgid "Dashboard"
msgstr "Conseil"

#: BSPQ20E3/panel/templates/basewithbar.html:71
msgid "Live log"
msgstr "Journal en direct"

#: BSPQ20E3/panel/templates/basewithbar.html:73
msgid "User"
msgstr "Utilisateur"

#: BSPQ20E3/panel/templates/basewithbar.html:98
msgid "Configuration"
msgstr "La configuration"

#: BSPQ20E3/panel/templates/basewithbar.html:101
msgid "Settings"
msgstr "Ajustements"

#: BSPQ20E3/panel/templates/index.html:16
msgid "Overall"
msgstr "Résumé"

#: BSPQ20E3/panel/templates/index.html:17
#, fuzzy
#| msgid "Social media"
msgid "Social Media"
msgstr "Informations"

#: BSPQ20E3/panel/templates/index.html:18
msgid "Recommendations"
msgstr "Recommandations"

#: BSPQ20E3/panel/templates/index.html:19
msgid "Economy"
msgstr "Économie"

#: BSPQ20E3/panel/templates/index.html:30
msgid "HEAT MAP OF CONFIRMED CASES"
msgstr "CARTE DE CHALEUR DES CAS CONFIRMÉS"

#: BSPQ20E3/panel/templates/index.html:39
msgid "CONFIRMED CASES THROUGH TIME"
msgstr "CAS CONFIRMÉS À TRAVERS LE TEMPS"

#: BSPQ20E3/panel/templates/index.html:46
msgid "DEATH NUMBER"
msgstr "NUMÉRO DE DÉCÈS"

#: BSPQ20E3/panel/templates/index.html:47
msgid "CONFIRMED CASES"
msgstr "CAS CONFIRMÉS"

#: BSPQ20E3/panel/templates/index.html:58
msgid "NEW CONFIRMED CASES"
msgstr "NOUVEAU CAS CONFIRMÉ"

#: BSPQ20E3/panel/templates/livelogtest.html:17
msgid "Filters"
msgstr "Filtres"

#: BSPQ20E3/panel/templates/livelogtest.html:28
msgid "Remove all filters"
msgstr "Effacer les filtres"

#: BSPQ20E3/panel/templates/livelogtest.html:34
msgid "Country_Region"
msgstr "Les pays"

#: BSPQ20E3/panel/templates/livelogtest.html:35
msgid "Confirmed"
msgstr "Confirmé"

#: BSPQ20E3/panel/templates/livelogtest.html:36
msgid "Deaths"
msgstr "Mort"

#: BSPQ20E3/panel/templates/livelogtest.html:37
msgid "Recovered"
msgstr "Récupéré"

#: BSPQ20E3/panel/templates/livelogtest.html:38
msgid "Last update"
msgstr "Dernier actualisation"

#: BSPQ20E3/panel/templates/livelogtest.html:78
#: BSPQ20E3/panel/templates/livelogtest.html:81
msgid "Previous"
msgstr "Précédent"

#: BSPQ20E3/panel/templates/livelogtest.html:94
#: BSPQ20E3/panel/templates/livelogtest.html:96
msgid "Next"
msgstr "Suivant"

#: BSPQ20E3/panel/templates/profile.html:15
msgid "Last login: "
msgstr "Dernière connexion: "

#: BSPQ20E3/panel/templates/profile.html:23
msgid "About"
msgstr "À propos"

#: BSPQ20E3/panel/templates/profile.html:26
msgid "Timeline"
msgstr "Chronologie"

#: BSPQ20E3/panel/templates/profile.html:36
#, fuzzy
#| msgid "Email address"
msgid "Email: "
msgstr "Courrier électronique"

#: BSPQ20E3/panel/templates/profile.html:40
msgid "Name: "
msgstr "Nom: "

#: BSPQ20E3/panel/templates/recommendations.html:13
msgid "https://www.youtube.com/embed/sHP0UIdZyI4"
msgstr "https://www.youtube.com/embed/p6wb37RbYk0"

#: BSPQ20E3/panel/templates/recommendations.html:17
msgid "COVID-19 is the name given to the disease associated with the virus."
msgstr "COVID-19 est le nom donné à la maladie associée au virus."

#: BSPQ20E3/panel/templates/recommendations.html:18
msgid ""
"SARS-CoV-2 is a new strain of coronavirus that has not been previously "
"identified in humans."
msgstr ""
"Le SRAS-CoV-2 est une nouvelle souche de coronavirus qui n'a pas encore été "
"identifiée chez l'homme."

#: BSPQ20E3/panel/templates/recommendations.html:37
msgid "What are they?"
msgstr "Quels sont-ils?"

#: BSPQ20E3/panel/templates/recommendations.html:38
msgid ""
"Coronaviruses are viruses that circulate among animals with some of them "
"also known to infect humans. Bats are considered natural hosts of these "
"viruses yet several other species of animals are also known to act as "
"sources. For instance, Middle East Respiratory Syndrome Coronavirus (MERS-"
"CoV) is transmitted to humans from camels, and Severe Acute Respiratory "
"Syndrome Coronavirus-1 (SARS-CoV-1) is transmitted to humans from civet cats."
msgstr ""
"Les coronavirus sont des virus qui circulent entre les animaux, et certains "
"d'entre eux sont également connus pour infecter les humains. Les chauves-"
"souris sont considérées comme des hôtes naturels de ces virus, bien que "
"d'autres espèces animales soient également connues pour agir comme sources. "
"Par exemple, le coronavirus du syndrome respiratoire du Moyen-Orient (MERS-"
"CoV) est transmis aux humains par les chameaux, et le coronavirus du "
"syndrome respiratoire aigu sévère (SARS-CoV-1) est transmis aux humains par "
"les chats."

#: BSPQ20E3/panel/templates/recommendations.html:55
msgid "Where does the virus come from?"
msgstr "D'où vient le virus?"

#: BSPQ20E3/panel/templates/recommendations.html:56
msgid ""
"While animals are believed to be the original source, the virus spread is "
"now from person to person (human-to-human transmission). There is not enough "
"epidemiological information at this time to determine how easily this virus "
"spreads between people, but it is currently estimated that, on average, one "
"infected person will infect between two and three other people. "
msgstr ""
"Alors que les animaux seraient la source d'origine, la propagation du virus "
"se fait désormais de personne à personne (transmission de personne à "
"personne). Il n'y a pas suffisamment d'informations épidémiologiques pour le "
"moment pour déterminer avec quelle facilité ce virus se propage entre les "
"personnes, mais on estime actuellement qu'en moyenne, une personne infectée "
"infectera deux à trois personnes de plus."

#: BSPQ20E3/panel/templates/recommendations.html:72
msgid "How is the virus transmitted?"
msgstr "Comment le virus se transmet-il?"

#: BSPQ20E3/panel/templates/recommendations.html:73
msgid ""
"The virus seems to be transmitted mainly via small respiratory droplets "
"through sneezing, coughing, or when people interact with each other for some "
"time in close proximity (usually less than one metre). These droplets can "
"then be inhaled, or they can land on surfaces that others may come into "
"contact with, who can then get infected when they touch their nose, mouth or "
"eyes. The virus can survive on different surfaces from several hours "
"(copper, cardboard) up to a few days (plastic and stainless steel). However, "
"the amount of viable virus declines over time and may not always be present "
"in sufficient numbers to cause infection."
msgstr ""
"Le virus semble être transmis principalement par de petites gouttelettes "
"respiratoires par les éternuements, la toux ou lorsque les gens "
"interagissent les uns avec les autres pendant un certain temps à proximité "
"(généralement moins d'un mètre). Ces gouttelettes peuvent ensuite être "
"inhalées, ou elles peuvent atterrir sur des surfaces avec lesquelles "
"d'autres peuvent entrer en contact, qui peuvent ensuite être infectées en "
"touchant leur nez, leur bouche ou leurs yeux. Le virus peut survivre sur "
"différentes surfaces de plusieurs heures (cuivre, carton) à quelques jours "
"(plastique et acier inoxydable). Cependant, la quantité de virus viables "
"diminue avec le temps et peut ne pas toujours être présente en nombre "
"suffisant pour provoquer une infection."

#: BSPQ20E3/panel/templates/recommendations.html:89
msgid "When does the transmission occur?"
msgstr "Quand la transmission a-t-elle lieu?"

#: BSPQ20E3/panel/templates/recommendations.html:90
msgid ""
"The incubation period for COVID-19 (i.e. the time between exposure to the "
"virus and onset of symptoms) is currently estimated to be between one and 14 "
"days."
msgstr ""
"La période d'incubation du COVID-19 (c'est-à-dire le temps entre "
"l'exposition au virus et l'apparition des symptômes) est actuellement "
"estimée entre un et 14 jours."

#: BSPQ20E3/panel/templates/recommendations.html:92
msgid ""
"We know that the virus can be transmitted when people who are infected show "
"symptoms such as coughing. There is also some evidence suggesting that "
"transmission can occur from a person that is infected even two days before "
"showing symptoms; however, uncertainties remain about the effect of "
"transmission by asymptomatic persons."
msgstr ""
"Nous savons que le virus peut être transmis lorsque les personnes infectées "
"présentent des symptômes tels que la toux. Il existe également des preuves "
"suggérant que la transmission peut se produire d'une personne infectée même "
"deux jours avant de montrer des symptômes; Cependant, des incertitudes "
"demeurent quant à l'effet de la transmission par des personnes "
"asymptomatiques."

#: BSPQ20E3/panel/templates/recommendations.html:109
msgid "What are the symptoms?"
msgstr "Quels sont les symptômes?"

#: BSPQ20E3/panel/templates/recommendations.html:112
msgid "Fever"
msgstr "La fièvre"

#: BSPQ20E3/panel/templates/recommendations.html:113
msgid "Cough"
msgstr "Toux"

#: BSPQ20E3/panel/templates/recommendations.html:114
msgid "Sore throat"
msgstr "Maux de gorge"

#: BSPQ20E3/panel/templates/recommendations.html:115
msgid "General weakness"
msgstr "Faiblesse générale"

#: BSPQ20E3/panel/templates/recommendations.html:116
msgid "Fatigue and muscular pain"
msgstr "Fatigue et douleurs musculaires"

#: BSPQ20E3/panel/templates/recommendations.html:117
msgid "Severe pneumonia"
msgstr "Pneumonie sévère"

#: BSPQ20E3/panel/templates/recommendations.html:118
msgid "Acute respiratory distress syndrome"
msgstr "Syndrome de détresse respiratoire aiguë"

#: BSPQ20E3/panel/templates/recommendations.html:120
msgid ""
"Symptoms of COVID-19 vary in severity from having no symptoms at all (being "
"asymptomatic) to having fever, cough, sore throat, general weakness and "
"fatigue and muscular pain and in the most severe cases, severe pneumonia, "
"acute respiratory distress syndrome, sepsis and septic shock, all "
"potentially leading to death. Reports show that clinical deterioration can "
"occur rapidly, often during the second week of disease."
msgstr ""
"La gravité des symptômes de COVID-19 varie de l'absence de symptômes "
"(asymptomatique) à la fièvre, la toux, le mal de gorge, la faiblesse et la "
"fatigue générales et la douleur musculaire et, dans les cas les plus graves, "
"la pneumonie sévère, le syndrome de détresse respiratoire aiguë, la "
"septicémie et choc septique, tous pouvant entraîner la mort. Les rapports "
"montrent que la détérioration clinique peut se produire rapidement, souvent "
"au cours de la deuxième semaine de maladie."

#: BSPQ20E3/panel/templates/recommendations.html:124
msgid ""
"Recently, anosmia – loss of the sense of smell – (and in some cases the loss "
"of the sense of taste) have been reported as a symptom of a COVID-19 "
"infection. There is already evidence from South Korea, China and Italy that "
"patients with confirmed SARS-CoV-2 infection have developed anosmia/"
"hyposmia, in some cases in the absence of any other symptoms."
msgstr ""
"Récemment, l'anosmie - perte du sens de l'odorat - (et dans certains cas, la "
"perte du sens du goût) a été signalée comme symptôme d'une infection au "
"COVID-19. Il existe déjà des preuves en Corée du Sud, en Chine et en Italie "
"que les patients présentant une infection confirmée par le SRAS-CoV-2 ont "
"développé une anosmie / hyposmie, dans certains cas en l'absence de tout "
"autre symptôme."

#~ msgid "Search for"
#~ msgstr "Recherche par"

#~ msgid "Language"
#~ msgstr "Langage"

#~ msgid "Countries"
#~ msgstr "Les pays"

#~ msgid "Evolution"
#~ msgstr "Évolution"

#~ msgid "Tweets by CoronavirusESP"
#~ msgstr "Tweets de CoronavirusESP"

#~ msgid "Tweets by Covid_19Time"
#~ msgstr "Tweets de Covid_19Time"

#~ msgid "Dynamic Chart"
#~ msgstr "Graphique dynamique"

#~ msgid "by TradingView"
#~ msgstr "De TradingView"

#~ msgid "Sign in with"
#~ msgstr "Commencez la session avec"

#~ msgid "COVID-19 cases in each country"
#~ msgstr "Cas COVID-19 dans chaque pays"

#~ msgid "Number of deaths in each country"
#~ msgstr "Nombre de décès dans chaque pays"

#~ msgid "Log in / Register"
#~ msgstr "Commencer la session / Enregistrer"

#~ msgid "Login"
#~ msgstr "Commencer la session"

#~ msgid "Register"
#~ msgstr "Enregistrer"

#~ msgid "Password"
#~ msgstr "Mot de passe"

#~ msgid "Remember password"
#~ msgstr "Mémoriser le mot de passe"

#~ msgid "Sign up"
#~ msgstr "S'inscrire"
